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Abstract
HbQ-India is a rare alpha chain variant that usually presents in the heterozygous state. Normally, 
HbQ-India is clinically silent. It becomes symptomatic when present in association with other condi-
tions. We report a case of HbQ-India with concomitant presence of iron deficiency anemia. 
A 16-year-old female presented with weakness and pallor intermittently for six years. Complete blood 
count showed severe microcytic hypochromic anemia. Hemoglobin electrophoresis showed a promi-
nent band in the S,D,G region. Tests for sickling were negative. High performance liquid chromatog-
raphy (HPLC) showed a peak in the unknown window (4.70-4.90 min) suggestive of HbQ-India. 
Serum iron profile was suggestive of iron deficiency anemia. Based on the above findings, a diagnosis 
of coexistent HbQ-India–iron deficiency anemia was made. A family study revealed the father as hav-
ing moderate anemia with similar findings while the mother was normal. Abnormal hemoglobin in the 
patient was confirmed by molecular diagnosis.
HbQ variants are the alpha globin chain variants due to structural mutations (α64 Asp→His) inher-
ited in autosomal dominant fashion. Three molecular variant types have been documented, namely 
HbQ-India, HbQ-Thailand and HbQ-Iran. Normally, HbQ is clinically silent. Therefore, careful screen-
ing of the samples using routine techniques like Hb electrophoresis and HPLC are needed for identi-
fication of such abnormal hemoglobin variants like HbQ-India. (Turk J Hematol 2010; 27: 200-3)
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Özet
Hb Q-India genelde heterozigoz durumda bulunan nadir bir alfa zincir varyantıdır. Normalde HbQ-
India klinik olarak sessizdir. Diğer koşulların varlığı ile birlikte semptomatik hale gelir. Biz burada, 
demir eksikliği anemisi ile eşzamanlı bir HbQ-India vakasını bildiriyoruz. 
Altı yaşından beri halsizlik ve gidip gelen solgunluğa sahip 16 yaşında bir kadın sunulmuştur. Tam kan 
sayımı şiddetli derecede mikrositik hipokromik anemi göstermiştir. Hemoglobin elektroforezi S, D, G Introduction
HbQ-India is a rare alpha globin chain variant 
and usually presents in the heterozygous state. 
Normally, HbQ-India is clinically silent. It becomes 
symptomatic when present in association with 
other conditions like beta-thalassemia, alpha-
thalassemia, HbE and HbH. We determined one 
such case in a Punjabi family. The hematological 
findings of the case along with the family study are 
presented.
Case Report
An 18-year-old female presented with complaints 
of weakness and pallor intermittently for six years. 
Physical examination showed severe pallor. No other 
significant finding was noted. The findings of the 
complete blood count (CBC) with erythrocyte sedi-
mentation rate (ESR) are summarized in Table 1. 
Peripheral smear showed severe microcytic 
hypochromic anemia. Hb electrophoresis (TEB 
Buffer pH 8.6) showed a prominent band in the S, 
D,G region in the patient and father while that of the 
mother showed a normal pattern. Test for sickling 
and solubility test were negative in both the patient 
and her father. Serum iron profile of the patient was: 
serum iron: 41 mg/dl, total iron-binding capacity 
(TIBC): 556 mg/dl, and transferrin saturation: 7.4%. 
High performance liquid chromatography (HPLC) 
showed a prominent peak in the unknown window 
(4.70-4.90 min) in both the patient (Figure 1) and 
her father. The exact percentages of various frac-
tions are summarized in Table 1. HbQ-India was 
found to be 19.5% in the patient and 22.5% in the 
father. Serum iron profile of father was: serum iron: 
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bölgesinde belirgin bant göstermiştir. Oraklaşma testleri negatiftir. High performance liquid chroma-
tography (HPLC) bilinmeyen pencerede (4,70-4,90 dakika) yaptığı pik ile HbQ-India öne sürmüştür. 
Serum demir profili ise demir eksikliği anemisine işaret etmiştir. Yukarıdaki bulgular temel alınarak 
eşlik eden HbQ-India-Demir eksikliği anemisi tanısı konmuştur. Aile çalışması annenin normal 
olmasına karşın babanın benzer bulgularla orta şiddette anemisi olduğunu ortaya çıkarmıştır. Hastada 
anormal hemoglobin moleküler teşhis ile onaylanmıştır.
Hb Q varyantları otozomal dominant şekilde kalıtılan yapısal mutasyonlardan ötürü (α64 Asp→His) 
alfa globin zincir varyantlarıdır. HbQ-India, HbQ-Thailand ve HbQ-Iran olmak üzere üç moleküler 
varyant türü belgelenmiştir. Normalde HbQ klinik olarak sessizdir. Bu nedenle Hb elektroforezi & 
HPLC gibi rutin tekniklerden yararlanılarak numunelerin dikkatle izlenmesi HbQ-India gibi anormal 
hemoglobin varyantlarının tanımlanabilmesi için gereklidir. (Turk J Hematol 2010; 27: 200-3)
Anahtar kelimeler: Hb Q India, Hb Q, Hemoglobin varyantları
Geliş tarihi:12 Mart 2008    Kabul tarihi: 8 Nisan 2009
Table 1. Results of complete blood count and percentages of various hemoglobin fractions obtained by HPLC
  Hb RBC Hct  MCV  MCH  MCHC  Retic.  HbA2 HbA  HbQ-  HbF
 g/dl  1012/L %  fl  pg  g/dl  %      India
Patient  5.8  3.52  18.8 53.3 16.4 30.7  1  0.9  72.8 19.5  <1
Father 9.5  5.07  32.9  65  18.7  26.8  3  0.9  64.2  22.5  <1
Mother  11.3 4.03 33.8  83.9 28 33.3  1  --  --  -- --
Patient  9.7 4.52 29.8 66 22.1 34  3.5 --  --  -- --
(Post iron therapy at  
3 months) 
Patient  12.9 4.65 38.9  84.1  27.8  33.1  1.5 --  --  -- --
(Post iron therapy at  
6 months) 
Father  11.8 5.12 36.2  71.3  23.5  32.8  4  --  --  -- --
(Post iron therapy at 
3 months) 
Father  14.2 5.02 47.1  93.6  28.6  31.2  2
(Post iron therapy at 
6  months)       38 mg/dl, TIBC: 489 mg/dl and transferrin saturation: 
8.7%, thereby explaining the significant anemia.  
Molecular diagnosis of the abnormal hemoglobin 
was confirmed using a method described previously 
[2]. The characteristic 370 bp fragment (Figure 2) 
was observed in the agarose gel electrophoresis. 
Based on the above findings, a diagnosis of coexis-
tent HbQ India-iron deficiency anemia was made. 
Following the diagnosis, the patient was placed on 
iron therapy and she showed improvement as 
shown in Table 1. At the six-month follow-up, the 
hematological parameters had returned to normal 
range. The father, who was initially reluctant to 
receive iron therapy, was counseled and he eventu-
ally agreed. At the six-month follow-up, his hemato-
logical parameters had returned to normal range. 
Oral informed of consent was ontained from the 
patient.
Discussion
HbQ variants are the alpha globin chain variants 
due to structural mutations. Three molecular vari-
ant types have been documented, namely HbQ-
India [1] (alpha 64 Asp to His), HbQ-Thailand (alpha 
74 Asp to His) and HbQ-Iran (alpha 75 Asp to His). 
Normally, HbQ-India is clinically silent. This is 
because the residue involved, α64 (E
 
13), is on the 
surface of the hemoglobin tetramer. However, 
charge changes at these positions do not affect the 
properties of the hemoglobin molecule [2].
The majority of the cases reported in the litera-
ture are in association with beta- thalassemia [3]. 
The quantity of the HbQ variant is determined by 
the ratio of alpha A, alpha Q and beta A globin 
chains. HbQ-India is also known to be affected by 
the presence of other hemoglobinopathies. 
Presence of alpha-thalassemia favors the formation 
of HbQ, whereas beta-thalassemia reduces the for-
mation of HbQ. This has been explained to be due 
to a post-translational control mechanism [4].
In the present case, the patient and her father 
improved remarkably on iron therapy. This rules out 
the possibility of any other associated hemoglobin-
opathy like alpha-thalassemia.
The definitive method for the identification of 
HbQ-India
 
is DNA sequencing of the alpha globin 
and beta
 
globin genes. However, it is an expensive 
technique and not practical
 
for routine use.
Amplification refractory mutation system (ARMS) 
polymerase chain reaction (PCR)  [2], which is a 
relatively inexpensive technique, has been adapted 
to enable the quick identification
 
of HbQ-India.
In conclusion, awareness about HbQ-India is 
important as it may be confused with HbS and HbD. 
HPLC and molecular techniques should be performed 
in cases with band in the S,D,G region and negative 
tests for sickling in order to exclude HbQ-India.
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Figure 1. HPLC of the patient showing a peak in the unknown 
window (4.70-4.90 min)
Figure 2. Agarose gel showing the characteristic 370 bp fragment 
(yellow arrow) in lane 4. Lane 3 - control showing the normal 766 
bp fragment (pink arrow), lane 1 -  X174 DNA marker fragments 
and lane 2 - water blankReferences
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